Tonix is a New Jersey-based biopharmaceutical company that researches and develops small molecules-based therapeutics for the treatment of CNS disorders.
Business Model:
Revenue: $2M
Employees: 51-200
Address: 26 Main Street
City: Chatham
State: NJ
Zip: 07928
Country: US
Tonix is a New Jersey-based biopharmaceutical company that researches and develops small molecules-based therapeutics for the treatment of CNS disorders.
Contact Phone:
+18627998599
Contact Email:
Listed Exchange:
NASDAQ
IPO Date:
1/29/2014
Ticker Symbol:
TNXP
Amount Raised:
$44M
Opened: -/share
EBITDA | - |
Total Cash | - |
Total Debt | - |
Total Revenue | - |
Total Profit (Gross) | - |
PE Ratio | - |
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 2/2015 | Post-IPO Equity | 3 | $28.7M |
Broadfin Capital Sabby Management Deerfield Broadfin Capital Sabby Management Deerfield |
7/2015 | Post-IPO Equity | $20.1M | 11/2012 | Debt Financing | $710k | 10/2011 | Debt Financing | $1.6M | 2/2021 | Post-IPO Equity | $70M | 6/2022 | Post-IPO Equity | $30M | 1/2014 | Post-IPO Equity | $43.5M | 11/2019 | Post-IPO Equity | $9M | 9/2017 | Equity | $314.8k | 7/2020 | Private Placement | $10.5M | 12/2012 | Convertible Note | $3.3M | 12/2012 | Private Placement | $2.3M | 12/2012 | Venture Round | 1 | $1M |
Technology Partners Technology Partners Technology Partners |
10/2016 | Post-IPO Equity | $5.2M | 3/2017 | Post-IPO Equity | $8M | 12/2012 | Post-IPO Equity | 1 | $1M |
Technology Partners Technology Partners Technology Partners Technology Partners |
1/2021 | Post-IPO Equity | $40M |
---|
Announced Date | Name | Price |
---|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|